Literature DB >> 35050820

Endovascular treatment of main trunk aneurysms in the residual anterior circulation in moyamoya disease.

Zibo Zhou1, Kan Xu1, Jinlu Yu1.   

Abstract

BACKGROUND: Main trunk aneurysms in the residual anterior circulation in moyamoya disease (MMD) are uncommon, and in such cases, endovascular treatment (EVT) is a good choice.
MATERIALS AND METHODS: A retrospective study was performed on 35 consecutive patients admitted to our hospital who were diagnosed with MMD and main trunk aneurysms in the residual anterior circulation and were treated with EVT. RESULT: The 35 patients were aged 38-77 years (mean, 56.1 ± 8.8 years) and included 17 females (48.6%, 17/35). There were 29 cases (82.9%, 29/35) of hemorrhagic onset. In 35 patients, there were 38 main trunk aneurysms in the residual anterior circulation. Thirty-eight aneurysms underwent coiling; among them, coiling with stent assistance was used in the treatment of 6 (15.8%, 6/38) aneurysms. The immediate modified Raymond-Roy classification (MRRC) was grade I for all aneurysms. Among 35 patients, intraoperative bleeding occurred in 2 (5.7%, 2/35) patients. After EVT, immediate hemiplegia occurred in 4 (11.4%, 4/35) patients, and immediate coma occurred in 1 (2.9%, 1/35) patient. At discharge, in 35 patients, the Glasgow Outcome Scale (GOS) was five in 88.6% of them. Of 35 patients, 68.6% had follow-up data, GOS was five in 87.5% patients, and the MRRC was grade I for all aneurysms in the follow-up angiography.
CONCLUSION: For main trunk aneurysms in the residual anterior circulation in MMD, although EVT was accompanied by potential ischemic and hemorrhagic complications, which should be considered, EVT can still offer an acceptable prognosis in more than 85% of patients.

Entities:  

Keywords:  Moyamoya disease; aneurysm; anterior circulation; endovascular treatment; main trunk

Mesh:

Year:  2022        PMID: 35050820      PMCID: PMC9513918          DOI: 10.1177/19714009211067413

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  30 in total

1.  Incidental major artery aneurysms in patients with non-hemorrhagic moyamoya disease.

Authors:  Je Young Yeon; Jong-Soo Kim; Seung-Chyul Hong
Journal:  Acta Neurochir (Wien)       Date:  2011-01-31       Impact factor: 2.216

2.  Effects of intravenous anesthesia with propofol on regional cortical blood flow and intracranial pressure in surgery for moyamoya disease.

Authors:  Ken-Ichiro Kikuta; Yasushi Takagi; Kazuhiko Nozaki; Keisuke Yamada; Susumu Miyamoto; Hiroharu Kataoka; Toshiyuki Arai; Nobuo Hashimoto
Journal:  Surg Neurol       Date:  2007-06-21

3.  Anesthetic management in a child with moya-moya disease and sickle cell anemia: Case report.

Authors:  M Vinícius Ribeiro E Silva; F Tavares Mendonça; R Garcia Dusi
Journal:  Rev Esp Anestesiol Reanim       Date:  2016-05-27

4.  Clinical and angiographic features and stroke types in adult moyamoya disease.

Authors:  D-K Jang; K-S Lee; H K Rha; P-W Huh; J-H Yang; I S Park; J-G Ahn; J H Sung; Y-M Han
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

Review 5.  Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases.

Authors:  S Kawaguchi; T Sakaki; T Morimoto; T Kakizaki; K Kamada
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

Review 7.  Treatment strategies for aneurysms associated with moyamoya disease.

Authors:  Lei Zhang; Kan Xu; Yandong Zhang; Xin Wang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-02-05       Impact factor: 3.738

8.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

9.  Moyamoya disease associated with arteriovenous malformation and anterior communicating artery aneurysm: A case report and literature review.

Authors:  Jinlu Yu; Yongjie Yuan; Duoduo Zhang; Kan Xu
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

10.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.